8-K/AFiled Aug 3, 8:00 PM ET
$BCRX · BIOCRYST PHARMACEUTICALS INCResearch Summary
AI-generated summary of this SEC filing
I don’t have access to external filings right now. Please paste the text of the Form 8‑K (or the Item 2.05 section) and I’ll produce the requested summary.
If it’s easier, provide these key details:
- Date of the charge/entry and filing date (here 2026-08-04)
- Total dollar amount of costs associated with exit/disposal activities
- Type of costs (severance, lease termination, asset write-downs, etc.)
- Timing / expected cash vs. non-cash, and expected period of impact (e.g., Q3 2026)
- Any statements about size of workforce affected or facilities closed
Once you paste those details I will generate the TITLE, SHORT_DESCRIPTION, and a 2–3 paragraph SUMMARY formatted exactly as you requested.